Onartuzumab Biosimilar (HGFR / c-Met Reference Antibody)
Onartuzumab (MetMAb) is a unique, humanized and affinity-matured monovalent (one-armed) monoclonal antibody against the MET receptor. Onartuzumab potently inhibits HGF binding and receptor phosphorylation and signaling. Onartuzumab has antibody-like pharmacokinetics and antitumor activity.
Product Specifications
Target
Onartuzumab Biosimilar (Anti-HGFR / c-Met Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Signal Transduction
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog